230 related articles for article (PubMed ID: 9708935)
1. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy.
Chang TC; Lai CH; Tseng CJ; Hsueh S; Huang KG; Chou HH
Cancer; 1998 Aug; 83(4):712-8. PubMed ID: 9708935
[TBL] [Abstract][Full Text] [Related]
2. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
[TBL] [Abstract][Full Text] [Related]
3. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide.
Morris M; Gershenson DM; Eifel P; Silva EG; Mitchell MF; Burke TW; Wharton JT
Gynecol Oncol; 1992 Oct; 47(1):62-5. PubMed ID: 1330847
[TBL] [Abstract][Full Text] [Related]
4. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.
Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC
Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
7. Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Yin ZM; Yu AJ; Wu MJ; Fang J; Liu LF; Zhu JQ; Yu H
Eur J Gynaecol Oncol; 2015; 36(3):326-9. PubMed ID: 26189262
[TBL] [Abstract][Full Text] [Related]
8. Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen.
Tokunaga H; Nagase S; Yoshinaga K; Tanaka S; Nagai T; Kurosawa H; Kaiho-Sakuma M; Toyoshima M; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Tohoku J Exp Med; 2013 Jan; 229(1):75-81. PubMed ID: 23269283
[TBL] [Abstract][Full Text] [Related]
9. Response of early stage bulky cervical squamous carcinoma to preoperative adjuvant chemotherapy.
Linghu H; Xu XR; Mei YY; Tang JY; Tang LD; Sun T
Chin Med Sci J; 2004 Jun; 19(2):116-9. PubMed ID: 15250247
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma.
Lai CH; Lin TS; Soong YK; Chen HF
Gynecol Oncol; 1989 Nov; 35(2):193-8. PubMed ID: 2478428
[TBL] [Abstract][Full Text] [Related]
11. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
12. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
14. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in stage IB neuroendocrine small cell carcinoma of the cervix.
Abulafia O; Sherer DM
Acta Obstet Gynecol Scand; 1995 Oct; 74(9):740-4. PubMed ID: 7572111
[TBL] [Abstract][Full Text] [Related]
16. Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor.
Kim DS; Moon H; Kim KT; Hwang YY; Cho SH; Kim SR
Gynecol Oncol; 1989 May; 33(2):225-30. PubMed ID: 2467848
[TBL] [Abstract][Full Text] [Related]
17. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
[TBL] [Abstract][Full Text] [Related]
20. Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE).
de Campos ES; Menasce LP; Radford J; Harris M; Thatcher N
Cancer; 1994 Jan; 73(2):470-5. PubMed ID: 8293415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
